Monitoring chimerism after transplant is critical to good health
Spring 2023 IDF ADVOCATE newsletter
Second bivalent dose allowed for those at high risk from COVID-19
Study looks at long-term response to COVID vaccine in immunocompromised
Community Q&A: primary immunodeficiency & neurological issues with Dr. Stacey Clardy
Primary immunodeficiency & neurological issues
Project ECHO clinician series: Steps to diagnosing a PI
Bold conversations part 2: The roots of medical mistrust among communities of color
ADMA Biologics
ADMA Biologics is relentlessly committed to creating products for immunodeficient patients at risk for infection.
Jeffrey Modell Foundation
The Jeffrey Modell Foundation (JMF) is a global nonprofit dedicated to early diagnosis, treatments, and ultimately, future cures for primary immunodeficiency through awareness, advocacy, and research.

